According to Aura Biosciences's latest financial reports the company has $0.22 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.18 B | 26.67% |
2021-12-31 | $0.14 B | 757.03% |
2020-12-31 | $17.39 M | -46.4% |
2019-12-31 | $32.44 M |